Xinhua News Agency, January 22nd: Sunnyou Medical released its 2024 earnings forecast. During the reporting period, it is expected to achieve operating revenue of 730 million to 750 million yuan, a year-on-yearDecrease of 1.99% to an increase of 0.70%The net profit attributable to the parent company's owners is expected to be between 95 million yuan and 110 million yuan, representing a year-on-year decrease of 51.57% to 58.18%. The net profit attributable to the parent company's owners excluding non-recurring gains and losses is expected to be between 82 million yuan and 95 million yuan, representing a year-on-year decrease of 53.44% to 59.81%.
Sunnyou Medical stated that during the reporting period, in the face of opportunities and challenges, the company adhered to technological innovation, continuously improved management levels and operational capabilities, and maintained revenue basically flat compared to the previous year. Meanwhile, the company continued to attract high-end rehabilitation technology talents and R&D personnel from various regions, leading to increased salaries and related expenses for R&D staff. Additionally, with the company's construction projects being successively put into use, depreciation and amortization rose compared to the previous year, resulting in a decline in net profit attributable to the parent company's owners and non-recurring profit and loss deductions.
Proofread by Yang Xuli